We are live on
!
Find out more
AC
Ascend Capital Portfolio holdings
AUM
$1.99B
1-Year Est. Return
10.36%
This Fund
S&P 500
This Quarter
Est. Return
+7.8%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
+$109M
(+7.1%)
Cap. Flow
-$39.4M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
32.41%
Holding
192
New
57
Increased
25
Reduced
32
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$81.3M |
| 2 |
Perrigo
PRGO
|
+$78.7M |
| 3 |
CSC
Computer Sciences
CSC
|
+$51.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$50.6M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$45.7M |
| 2 |
Trane Technologies
TT
|
+$38.4M |
| 3 |
Lithia Motors
LAD
|
+$30.6M |
| 4 |
PE
PARSLEY ENERGY INC
PE
|
+$27.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$27.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.46% |
| 2 | Industrials | 12.93% |
| 3 | Technology | 10.32% |
| 4 | Energy | 9.83% |
| 5 | Communication Services | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Devon Energy
DVN
$51.9B
| $1.1M | 0.07% |
25,000
-130,963
| -84% | -$5.32M |
|
|
XEC
102
DELISTED
CIMAREX ENERGY CO
XEC
| $1.07M | 0.07% |
8,000
-131,107
| -94% | -$16.4M |
|
|
GLOG
103
DELISTED
GASLOG LTD
GLOG
| $946K | 0.06% |
+65,000
| New | +$884K |
|
|
KATE
104
DELISTED
Kate Spade & Company
KATE
| $857K | 0.05% |
+50,000
| New | +$969K |
|
|
NXEOW
105
DELISTED
Nexeo Solutions, Inc. Warrant
NXEOW
| $818K | 0.05% |
1,320,188
-18,812
| -1% | -$13.1K |
|
106
United Rentals
URI
$71.1B
| $785K | 0.05% |
+10,000
| New | +$766K |
|
107
uniQure
QURE
$2.68B
| $765K | 0.05% |
100,000
-120,000
| -55% | -$952K |
|
108
Voyager Therapeutics
VYGR
$187M
| $700K | 0.04% |
+58,267
| New | +$789K |
|
|
NXEO
109
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $412K | 0.03% |
+50,000
| New | +$441K |
|
|
ADAP
110
DELISTED
Adaptimmune Therapeutics
ADAP
| $353K | 0.02% |
50,000
-164,794
| -77% | -$1.26M |
|
|
PDLI
111
DELISTED
PDL BioPharma, Inc.
PDLI
| $335K | 0.02% |
+100,000
| New | +$317K |
|
|
CRC
112
DELISTED
California Resources Corporation
CRC
| $311K | 0.02% |
24,872
-737,949
| -97% | -$8.42M |
|
|
CELGZ
113
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $35K | ﹤0.01% |
34,306
-16,408
| -32% | -$19.8K |
|
|
AIV
114
Aimco
AIV
$380M
| – | – |
-2,405,961
| Closed | -$14.2M |
|
115
Axos Financial
AX
$5.45B
| – | – |
-1,119,446
| Closed | -$19.8M |
|
116
Atlanta Braves Holdings Series A
BATRA
$3.53B
| – | – |
-450,000
| Closed | -$6.77M |
|
117
Atlanta Braves Holdings Series B
BATRK
$3.23B
| – | – |
-1,535,000
| Closed | -$22.5M |
|
118
Biogen
BIIB
$29.9B
| – | – |
-5,070
| Closed | -$1.23M |
|
|
119
Bristol-Myers Squibb
BMY
$127B
| – | – |
-370,293
| Closed | -$27.2M |
|
120
Citigroup
C
$222B
| – | – |
-75,000
| Closed | -$3.18M |
|
121
Conagra Brands
CAG
$7.07B
| – | – |
-227,299
| Closed | -$8.46M |
|
122
Avis
CAR
$5.63B
| – | – |
-539,112
| Closed | -$17.4M |
|
123
Celanese
CE
$5.09B
| – | – |
-75,000
| Closed | -$4.91M |
|
124
Costco
COST
$415B
| – | – |
-75,000
| Closed | -$11.8M |
|
125
CSX Corp
CSX
$98.6B
| – | – |
-300,000
| Closed | -$2.61M |
|
Similar funds
MWAC
TP
PC
RW
TBC
BWCA
AC
GCM
Ascend Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Ascend Capital held 192 positions worth $1.63B, up 7.1% from $1.53B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ascend Capital's Q3 2016 filing shows 57 new, 25 increased, 32 reduced and 74 closed positions. Its largest new stake was Endo International plc: 4,091,441 shares worth $82.4M. The largest sale was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $45.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.
- Ascend Capital's largest Q3 2016 buy was Endo International plc: 4,091,441 shares worth $82.4M.
- Ascend Capital added most to Alphabet (Google) Class A in Q3 2016, an estimated $50.6M increase.
- Ascend Capital's biggest Q3 2016 reduction was PARSLEY ENERGY INC, cutting an estimated $27.6M.
- Ascend Capital fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2016, selling an estimated $45.7M.
- Ascend Capital's ten largest holdings make up 32% of its $1.63B portfolio in Q3 2016.
- Ascend Capital opened 57 new positions and closed 74 in Q3 2016.
- Ascend Capital's portfolio value rose 7.1% quarter-over-quarter to $1.63B.
Based on Ascend Capital's 13F filing for Q3 2016, filed 14 Nov 2016.